紫月直播_紫月直播app官方正版下载_紫月直播高品质美女在线视频互动社区
About us
Our Values
Development Milestone
Products
Product List for API
Recommended API
Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
Contract Manufacturing
API and Pharmaceutical Intermediates
OTC and Generics
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Contact Us
中文版
舊版入口
About us
News
Investor Relation
Products
Contract Manufacturing
Contact Us
Investor Relation
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Reply Slip for the First Extraordinary General Meeting for the Year 2024
2024-10-03
Proxy Form for the First Extraordinary General Meeting for the Year 2024
2024-10-03
Notice of Extraordinary General Meeting
2024-10-03
Proposed Amendments to the Articles of Association, the Rules and Procedures for General Meetings,Board Meetings and Supervisors Meetings and Notice of Extraordinary General Meeting
2024-10-03
Proposed Amendments to the Articles of Association and Relevant Rules and Procedures
2024-09-30
Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information
2024-09-13
Overseas regulatory announcement-Announcement on Obtaining Approval Notice for Supplementary Drug Application and Other Relevant Information
2024-09-03
Overseas Regulatory Announcement-Announcement on Esomeprazole Magnesium Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs
2024-09-02
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2024
2024-09-02
Overseas Regulatory Announcement-Announcement on the Progress of Clinical Trial of OAB-14 Dry Suspension
2024-08-22
<
1
2
3
4
5
6
7
...
>